Significance of preoperative evaluation of modified advanced lung cancer inflammation index for patients with resectable non-small cell lung cancer.
Seijiro SatoRyo SezakiHirohiko Shinohara
Published in: General thoracic and cardiovascular surgery (2024)
Preoperative mALI appears to offer an independent predictor of poor surgical outcomes as a simple, routinely available, and inexpensive biomarker in patients with resectable NSCLC.